The global biocompatible 3D printing materials market size was estimated at USD 590.6 million in 2023 and is projected to grow at a CAGR of 14.3% from 2024 to 2030. Advancements in 3D printing techniques, including developing specialized biocompatible materials, enable the creation of patient-specific devices with enhanced functionality and improved integration with the human body. For instance, in August 2023, Materialise got involved in developing customized implants and surgical guides using biocompatible materials through its advanced 3D printing technologies. Their contributions highlight how personalized medicine drives the adoption of biocompatible 3D printing materials in various healthcare applications.
There is an increasing demand in the healthcare industry for biocompatible materials for various medical applications, such as implants, prosthetics, and tissue engineering. These materials are compatible with the human body to minimize the risk of rejection or adverse reactions, driving the need for advanced biocompatible 3D printing materials.
Technological advancements in 3D printing include significantly driven the market. The development of new materials and processes has enabled the creation of biocompatible materials that are safe for use in medical applications such as implants, prosthetics, and tissue engineering. For instance, CELLINK, a leading bio printing company, has developed bioinks that mimic human tissues’ properties for more accurate and reliable tissue engineering applications.
The growing adoption of personalized medicine has significantly driven the biocompatible 3D printing materials market. Personalized medicine aims to provide tailored medical treatment to patients based on their unique genetic makeup, lifestyle, and other factors. In the context of 3D printing, this approach allows for the creation of customized medical devices, implants, and pharmaceuticals specifically designed to meet the needs of each patient.
Polymer segment dominated the market and accounted for a share of 43.4% in 2023. Polymers are widely used in 3D printing due to their versatility and ability to be easily manipulated into complex shapes. This makes them ideal for various medical applications such as prosthetics, implants, and surgical guides. For instance, polylactic acid (PLA) and polyethylene glycol (PEG) are commonly used in biocompatible 3D printing due to their biodegradability and compatibility with human tissues.
The other segment is experiencing the significant growth due to its diverse range of materials that cater to specific niche applications. This segment includes hydrogels, ceramics, and composites that offer unique properties suitable for various biomedical and healthcare applications. For instance, hydrogels are gaining traction in tissue engineering and drug delivery systems due to their biocompatibility and ability to mimic biological tissues.
The implants and prosthesis segment dominated the market and accounted for a share of 29.8% in 2023 due to its critical role in revolutionizing healthcare by offering customized solutions for patients needing implants or prosthetic devices. This segment benefits significantly from the advancements in 3D printing technology, allowing for the production of complex and personalized implants that perfectly fit the patient’s anatomy. For instance, the adoption of 3D-printed PMMA implants is rising in total joint replacement procedures, including hip, knee, and shoulder surgeries. These customized implants offer superior biocompatibility, precise fit, and long-term durability, improving joint function and patient satisfaction.
Moreover, the customization and personalization capabilities offered by 3D printing technology allow for the creation of implants and prosthetics that perfectly fit an individual’s unique anatomy, leading to improved comfort and functionality. For instance, in September 2023, Unicorn Denmart Ltd. stated that 3D-printed dental implants can be tailored precisely to a patient’s jaw structure, enhancing aesthetics and functionality.
In North America, the market is witnessing significant growth driven by increasing investments in healthcare, rising demand for personalized medical devices, and advancements in 3D printing technologies. The region has a well-established healthcare infrastructure and a high adoption rate of innovative technologies, further fuelling the demand for biocompatible materials.
The U.S. is a critical player in the market, with a robust healthcare sector and a strong focus on research and development. Technological trends are moving toward developing advanced materials that are not only biocompatible but also offer enhanced mechanical properties, improved printability, and better biodegradability. For instance, in March 2022, Evonik introduced a range of high-performance polymers suitable for medical applications, including biocompatible materials for 3D printing implants and medical devices.
In Europe, the market is characterized by a growing emphasis on sustainability and environmental consciousness. European countries' stringent regulations regarding material safety and ecological impact influence the adoption of biocompatible materials in 3D printing applications.
The Asia Pacific market is experiencing rapid growth due to increasing healthcare expenditures, awareness about personalized medicine, and technological advancements. Countries including China, Japan, and South Korea are at the forefront of adopting 3D printing technologies for medical applications.
The market is dominated by several key players, each contributing unique innovations and capabilities. Companies are driving the growth of the market through continuous innovation, strategic acquisitions, and expanding production capabilities to cater to the increasing demand for personalized, patient-specific medical solutions.
The following are the leading companies in the biocompatible 3D printing materials market. These companies collectively hold the largest market share and dictate industry trends.
In April 2024, Formlabs unveiled the Form 4B, a next-generation resin 3D printer that redefines industry standards. Leveraging advancements in hardware, software, and materials, the Form 4B delivers unprecedented printing speed without compromising accuracy or surface finish, representing a significant evolution in stereolithography (SLA) technology.
In April 2024, Materialise and Renishaw formed a partnership to enhance the efficiency and productivity of manufacturers using Renishaw’s additive manufacturing systems. This collaboration involves Materialise providing customized build processor software for Renishaw’s metal AM systems, specifically the RenAM 500 series.
In May 2023, 3D Systems, a 3D printing company, acquired Wematter Gravity, a Swedish firm that provides an affordable selective laser sintering (SLS) 3D printing solution. This acquisition expands 3D Systems’ portfolio, particularly in the dental 3D printing segment.
In April 2022, Sandvik expanded its additive manufacturing capabilities by introducing 3D-printed biocompatible materials in cemented carbide. This new offering is made possible through Sandvik's patented process and the in-house production of customized powder.
Report Attribute |
Details |
Market size value in 2024 |
USD 664.7 million |
Revenue forecast in 2030 |
USD 1.5 billion |
Growth Rate |
CAGR of 14.3% from 2024 to 2030 |
Actual data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, application, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait |
Key companies profiled |
Formlabs Inc.; 3D Systems Inc.; Evonik Industries AG; Stratasys; Concept Laser Gmbh; Renishaw plc; ENVISIONTEC US LLC; Cellink; DETAX Ettlingen; Hoganas AB |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global biocompatible 3D Printing Materials market report on the basis of type, application, and region
Type Outlook (Revenue, USD Million, 2018 - 2030)
Polymer
Metal
Others
Application Outlook (Revenue, USD Million, 2018 - 2030)
Implants & Prosthesis
Prototyping & Surgical Guides
Tissue Engineering
Hearing Aids
Others
Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global biocompatible 3D printing materials market size was estimated at USD 590.6 million in 2023 and is expected to reach USD 664.7 million in 2024.
b. The global biocompatible 3D printing materials market is expected to grow at a compound annual growth rate of 14.3% from 2024 to 2030 to reach USD 1.5 billion by 2030.
b. North America dominated the biocompatible 3D printing materials market with a share of 37.03% in 2023. This is attributable to increasing investments in healthcare, rising demand for personalized medical devices, and advancements in 3D printing technologies.
b. Some prominent players in the biocompatible 3D printing materials market include: • Formlabs Inc. • 3D Systems Inc. • Evonik Industries AG • Stratasys • Concept Laser Gmbh • Renishaw plc • ENVISIONTEC US LLC • Cellink • DETAX Ettlingen • Hoganas AB
b. Key factors that are driving the market growth include Advancements in 3D printing techniques, such as developing specialized biocompatible materials, enabling the creation of patient-specific devices with enhanced functionality and improved integration with the human body
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."